Acrivon Therapeutics annual total assets
2021
2022
2023
2024
2025
Acrivon Therapeutics Total Assets Growth & History (ACRV)
Acrivon Therapeutics's total assets was $129.7M for fiscal 2025.
View full Acrivon Therapeutics company overviewAcrivon Therapeutics annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $129.7M | −$66.9M | −34.02% |
| 2024 | 2024-12-31 | $196.6M | $58.3M | +42.18% |
| 2023 | 2023-12-31 | $138.3M | −$43.0M | −23.71% |
| 2022 | 2022-12-31 | $181.2M | $74.6M | +70.03% |
| 2021 | 2021-12-31 | $106.6M | — | — |
Acrivon Therapeutics quarterly total assets
Q4.21
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $99.1M | −$59.5M | −37.51% |
| Q1 2026 | 2026-03-31 | $107.8M | −$68.5M | −38.85% |
| Q4 2025 | 2025-12-31 | $129.7M | −$66.9M | −34.02% |
| Q3 2025 | 2025-09-30 | $145.3M | −$69.4M | −32.32% |
| Q2 2025 | 2025-06-30 | $158.6M | −$72.0M | −31.23% |
| Q1 2025 | 2025-03-31 | $176.3M | $55.8M | +46.32% |
| Q4 2024 | 2024-12-31 | $196.6M | $58.3M | +42.18% |
| Q3 2024 | 2024-09-30 | $214.7M | $63.6M | +42.09% |
| Q2 2024 | 2024-06-30 | $230.6M | $70.5M | +44.07% |
| Q1 2024 | 2024-03-31 | $120.5M | −$49.7M | −29.19% |
| Q4 2023 | 2023-12-31 | $138.3M | −$43.0M | −23.71% |
| Q3 2023 | 2023-09-30 | $151.1M | $63.4M | +72.26% |
| Q2 2023 | 2023-06-30 | $160.0M | — | — |
| Q1 2023 | 2023-03-31 | $170.2M | — | — |
| Q4 2022 | 2022-12-31 | $181.2M | $74.6M | +70.03% |
| Q3 2022 | 2022-09-30 | $87.7M | — | — |
| Q4 2021 | 2021-12-31 | $106.6M | — | — |
Acrivon Therapeutics total assets trends
Between the periods ended 2021-12-31 and 2025-12-31, Acrivon Therapeutics's total assets increased from $106.6M to $129.7M, a change of $23.1M. The latest reported quarter, Q2 2026, shows $99.1M.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Acrivon Therapeutics source filings ↗